No items to display
In This Section
Substance Use Disorders Institute
Almost every one of us has been impacted. Driven by excessive opioid pain medication use and an unprecedented flood of deadly heroin and fentanyl, drug overdose deaths have skyrocketed, resulting in hundreds of lives lost a day and an epidemic deadlier than the 1990s HIV/AIDS crisis. One in four children lives in a family affected by alcohol or substance misuse.
The costs to individuals, families, and our communities have been devastating. All healthcare professionals should feel called to action to address the public health crisis we face. But gaps in knowledge and training—in addition to pervasive stigma—perpetuate ineffective treatments
The solution: a research- and evidence-based approach.
The Substance Use Disorders Institute (SUDI) at USciences translates science into policy and practice and improves substance use disorders care.
Our work includes
Improving patient care by educating healthcare professionals about substance use disorder risk factors, prevention, and treatment.
Synthesizing and analyzing scientific evidence.
Providing recommendations to decision-makers to inform healthcare and drug policy choices.
Conducting impactful preclinical, clinical, health policy, and public health research.
With more states requiring healthcare providers to improve their education and credentials, SUDI provides critical training and certification courses. And by convening the top subject matter experts for lecture series and other discussions, SUDI serves as a regional hub for substance use education, recovery resources, and legislative progress.
Debating the Impact of Medical Cannabis on the Opioid Crisis
May 11, 2018
Could access to medical cannabis impact the opioid epidemic? This was the topic of the most recent "Making the Connections" series presented by Mayes College in connection with the Substance Use Disorders Institute (SUDI).
USciences and Franklin BioScience, a Leading Medical Cannabis Innovator, Announce Collaboration
December 19, 2017
Agreement Builds on USciences excellence in research and education; leverages Franklin BioScience's expertise and knowledge of the cannabis plant and deep history of bringing innovative science-backed medical cannabis products to patients.